Briacell Therapeutics
Price & Volume
Stats
See moreOpen | $3.54 |
Previous Close | $3.53 |
Day Range | $3.47-$3.55 |
52W Range | $3-$45.60 |
Market Cap | $13M |
Shares Short | 202,320 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$13.35 |
News
See moreYahoo Finance • last year
BriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic Tumor
Yahoo Finance • 2 years ago
FDA Approves BriaCell’s Pivotal Registrational Study Design in Advanced Metastatic Breast Cancer
About
CEO | Dr. William V. Williams M.D. |
CFO | Mr. Gadi Levin B.Com., C.A., CPA, M.B.A. |
Address | Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
